166 related articles for article (PubMed ID: 22670779)
1. Comparison of American and European practices in the management of patients with primary immunodeficiencies.
Hernandez-Trujillo HS; Chapel H; Lo Re V; Notarangelo LD; Gathmann B; Grimbacher B; Boyle JM; Hernandez-Trujillo VP; Scalchunes C; Boyle ML; Orange JS
Clin Exp Immunol; 2012 Jul; 169(1):57-69. PubMed ID: 22670779
[TBL] [Abstract][Full Text] [Related]
2. Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: A working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology.
Yong PL; Boyle J; Ballow M; Boyle M; Berger M; Bleesing J; Bonilla FA; Chinen J; Cunninghamm-Rundles C; Fuleihan R; Nelson L; Wasserman RL; Williams KC; Orange JS
Clin Immunol; 2010 May; 135(2):255-63. PubMed ID: 19914873
[TBL] [Abstract][Full Text] [Related]
3. The case for a national service for primary immune deficiency disorders in New Zealand.
Ameratunga R; Steele R; Jordan A; Preece K; Barker R; Brewerton M; Lindsay K; Sinclair J; Storey P; Woon ST
N Z Med J; 2016 Jun; 129(1436):75-90. PubMed ID: 27355232
[TBL] [Abstract][Full Text] [Related]
4. [Patient support for primary immunodeficiency with hypogammaglobulinemia and intravenous immunoglobulin substitution: result of a national survey].
Suarez F; Puget S; Beaudet R; Goulamhoussen N; Hermine O
Presse Med; 2010 Mar; 39(3):e45-51. PubMed ID: 20122813
[TBL] [Abstract][Full Text] [Related]
5. [The ESID Online Database for primary immunodeficiencies. First analyses with regard to Germany and Europe].
Knerr V; Gathmann B; Eades-Perner AM; Kindle G; Grimbacher B
Med Klin (Munich); 2008 Sep; 103(9):620-7. PubMed ID: 18813884
[TBL] [Abstract][Full Text] [Related]
6. [Understanding primary immunodeficiencies: usefulness of a register].
Jandus P; Grange E; Seebach JD
Rev Med Suisse; 2016 Apr; 12(513):708, 710-2. PubMed ID: 27197327
[TBL] [Abstract][Full Text] [Related]
7. Intravenous and subcutaneous immunoglobulin replacement: a two-way road. Optimizing healthcare quality in patients with primary immunodeficiencies.
Soler-Palacín P; Gasó-Gago I; Fernández-Polo A; Martín-Nalda A; Oliveras M; Martinez-Cutillas J; Figueras C
J Clin Immunol; 2014 Nov; 34(8):1015-7. PubMed ID: 25190197
[TBL] [Abstract][Full Text] [Related]
8. Pulmonologist perspectives regarding diagnosis and management of primary immunodeficiency diseases.
Orange JS; Akhter J; Seeborg FO; Boyle M; Scalchunes C; Hernandez-Trujillo V
Allergy Asthma Proc; 2016 Nov; 37(6):162-168. PubMed ID: 27931293
[TBL] [Abstract][Full Text] [Related]
9. Management of primary antibody deficiency by consultant immunologists in the United Kingdom: a paradigm for other rare diseases.
Spickett GP; Askew T; Chapel HM
Qual Health Care; 1995 Dec; 4(4):263-8. PubMed ID: 10156396
[TBL] [Abstract][Full Text] [Related]
10. The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008.
Gathmann B; Grimbacher B; Beauté J; Dudoit Y; Mahlaoui N; Fischer A; Knerr V; Kindle G;
Clin Exp Immunol; 2009 Sep; 157 Suppl 1(Suppl 1):3-11. PubMed ID: 19630863
[TBL] [Abstract][Full Text] [Related]
11. Clinical ambiguities--ongoing questions.
Torgerson TR; Bonagura VR; Shapiro RS
J Clin Immunol; 2013 Jan; 33 Suppl 2():S99-103. PubMed ID: 23242829
[TBL] [Abstract][Full Text] [Related]
12. The European internet-based patient and research database for primary immunodeficiencies: update 2011.
Gathmann B; Binder N; Ehl S; Kindle G;
Clin Exp Immunol; 2012 Mar; 167(3):479-91. PubMed ID: 22288591
[TBL] [Abstract][Full Text] [Related]
13. 7th International Immunoglobulin Conference: Poster presentations.
Warnatz K; Ballow M; Stangel M; Bril V
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):162. PubMed ID: 25546805
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Effectiveness of the 6 Warning Signs of the European Society for Immunodeficiencies for Primary Immunodeficiencies in Older Adults.
Yildiz E; Çölkesen F; Evcen R; Sadi Aykan F; Kılınç M; Arslan S
Int Arch Allergy Immunol; 2024; 185(4):402-410. PubMed ID: 38219730
[TBL] [Abstract][Full Text] [Related]
15. How effective are the 6 European Society of Immunodeficiency warning signs for primary immunodeficiency disease?
Arslan S; Ucar R; Caliskaner AZ; Reisli I; Guner SN; Sayar EH; Baloglu I
Ann Allergy Asthma Immunol; 2016 Feb; 116(2):151-155.e1. PubMed ID: 26815708
[TBL] [Abstract][Full Text] [Related]
16. Evaluating dose ratio of subcutaneous to intravenous immunoglobulin therapy among patients with primary immunodeficiency disease switching to 20% subcutaneous immunoglobulin therapy.
Krishnarajah G; Lehmann JK; Ellman B; Bhak RH; DerSarkissian M; Leader D; Bullinger AL; Sheng Duh M
Am J Manag Care; 2016 Oct; 22(15 Suppl):s475-s481. PubMed ID: 27849353
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of patients with primary antibody deficiencies in Germany].
Borte M; Oertelt C; Högy B
Klin Padiatr; 2005; 217(5):276-80. PubMed ID: 16167275
[TBL] [Abstract][Full Text] [Related]
18. Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America.
Condino-Neto A; Costa-Carvalho BT; Grumach AS; King A; Bezrodnik L; Oleastro M; Leiva L; Porras O; Espinosa-Rosales FJ; Franco JL; Sorensen RU
Allergol Immunopathol (Madr); 2014; 42(3):245-60. PubMed ID: 23333411
[TBL] [Abstract][Full Text] [Related]
19. Economic benefits of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency.
Martin A; Lavoie L; Goetghebeur M; Schellenberg R
Transfus Med; 2013 Feb; 23(1):55-60. PubMed ID: 23167310
[TBL] [Abstract][Full Text] [Related]
20. Cost-utility analysis comparing hospital-based intravenous immunoglobulin with home-based subcutaneous immunoglobulin in patients with secondary immunodeficiency.
Windegger TM; Nghiem S; Nguyen KH; Fung YL; Scuffham PA
Vox Sang; 2019 Apr; 114(3):237-246. PubMed ID: 30883804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
